Robert F. Grover - Concepedia

Author

Robert F. Grover

Also Known As

R F Grover, R GROVER, ROBERT F. GROVER, ROBERT GROVER, ROBERT F. GROVER, Robert F Grover, Robert F. Grover, Robert Grover, Robert F. Grover

129

Publications

5.6K

Citations

H-Index

110

Concepts

All Affiliations

University of Colorado Boulder University of Colorado Denver University of Colorado Health

About

Robert F. Grover is an author at University of Colorado Boulder specializing in medicine, physiology, and pulmonary physiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	26	35	2.7K
2	Health Sciences	16	18	1.4K
3	Engineering	2	2	79
4	Education	1	1	27
5	Natural Sciences	1	1	96

Robert F. Grover

Publications

5.2K

Citations

H-Index

Page 1

	Year	Citations
Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: Effect on survival in patients with septic shock* Ángel Crespo López, José A. Lorente, Jay S. Steingrub, Critical Care Medicine	2004	917
Hypoxic ventilatory drive in normal man John V. Weil, E. Byrne-Quinn, I. E. Sodal, Journal of Clinical Investigation Pulmonary CirculationVentilationPhysiologyIsocapnic HypoxiaHypoxia (Medicine)	1970	429
Acquired attenuation of chemoreceptor function in chronically hypoxic man at high altitude John V. Weil, E. Byrne-Quinn, I. E. Sodal, Journal of Clinical Investigation AsthmaPhysical ActivityKinesiologyBody CompositionExercise	1971	205
Abnormal Circulatory Responses to High Altitude in Subjects with a Previous History of High-Altitude Pulmonary Edema Herbert N. Hultgren, Robert F. Grover, L. Howard Hartley Circulation Acute Lung InjuryHypertensionHigh-altitude Pulmonary EdemaPulmonary HypertensionAbnormal Circulatory Responses	1971	201
An open-label dose escalation study of the nitric oxide synthase inhibitor, NG-methyl-L-arginine hydrochloride (546C88), in patients with septic shock Robert F. Grover, David Zaccardelli, Gene Colice, Critical Care Medicine	1999	200
Administration of the nitric oxide synthase inhibitor NG-methyl-l-arginine hydrochloride (546C88) by intravenous infusion for up to 72 hours can promote the resolution of shock in patients with severe sepsis: Results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002)* Jan Bakker, Robert F. Grover, Angela McLuckie, Critical Care Medicine	2004	194
High-Altitude Pulmonary Edema in Persons without the Right Pulmonary Artery Peter H. Hackett, C. Edward Creagh, Robert F. Grover, New England Journal of Medicine Acute Lung InjuryDr. HoustonHeart FailurePulmonary Arterial HypertensionPulmonary Circulation	1980	174
The red cell mass-arterial oxygen relationship in normal man John V. Weil, Gail Jamieson, Donald W. Brown, Journal of Clinical Investigation HypertensionRedox BiologyCellular PhysiologyOxidative StressChronic Hypoxia	1968	168
Fluid Retention and Relative Hypoventilation in Acute Mountain Sickness Peter H. Hackett, Drummond Rennie, S. E. Hofmeister, Respiration Fluid RetentionHigh AltitudeDrowningBody CompositionAltitude Hypoxia	1982	144
Cardiovascular effects of the nitric oxide synthase inhibitor NG-methyl-l-arginine hydrochloride (546C88) in patients with septic shock: Results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002)* David I. Watson, Robert F. Grover, Antonio Anzueto, Critical Care Medicine	2004	129

Page 1